Hepatitis C virus and lipid droplets: Finding a niche

Trends in Molecular Medicine

Volumn 21, Issue 1, 2015, Pages 34-42

  Filipe, Ana ^a   McLauchlan, John ^a  

^a MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

Author keywords

HCV; Lipid droplets; Protein targeting; Steatosis; Virion assembly; VLDL

Indexed keywords

FAT DROPLET; NONSTRUCTURAL PROTEIN 5A; VERY LOW DENSITY LIPOPROTEIN;

3' UNTRANSLATED REGION; AMINO TERMINAL SEQUENCE; ENDOPLASMIC RETICULUM MEMBRANE; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; GLUCONEOGENESIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIPID STORAGE; LIPOGENESIS; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN MOTIF; PROTEIN STABILITY; PROTEIN TARGETING; REVIEW; RNA REPLICATION; VIRUS ASSEMBLY; VIRUS PARTICLE; ANIMAL; GENETICS; HEPACIVIRUS; LIPID METABOLISM; METABOLISM; PHYSIOLOGY; VIROLOGY;

HEPATITIS C VIRUS;

ANIMALS; HEPACIVIRUS; HEPATITIS C; HUMANS; LIPID DROPLETS; LIPID METABOLISM;

EID: 84927623326     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2014.11.003     Document Type: Review

References (99)

1. Cheung W., et al. Rotaviruses associate with cellular lipid droplet components to replicate in viroplasms, and compounds disrupting or blocking lipid droplets inhibit viroplasm formation and viral replication. J. Virol. 2010, 84:6782-6798.
2. Seo J.Y., Cresswell P. Viperin regulates cellular lipid metabolism during human cytomegalovirus infection. PLoS Pathog. 2013, 9:e1003497.
3. Samsa M.M., et al. Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog. 2009, 5:e1000632.
4. Cocchiaro J.L., et al. Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:9379-9384.
5. Elamin A.A., et al. Lipid droplets and Mycobacterium leprae infection. J. Pathog. 2012, 2012:361374.
6. Gross D.A., Silver D.L. Cytosolic lipid droplets: from mechanisms of fat storage to disease. Crit. Rev. Biochem. Mol. Biol. 2014, 49:304-326.
7. Pol A., et al. Review: biogenesis of the multifunctional lipid droplet: lipids, proteins, and sites. J. Cell Biol. 2014, 204:635-646.
8. Moradpour D., et al. Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. Virology 1996, 222:51-63.
9. Targett-Adams P., et al. Maturation of hepatitis C virus core protein by signal peptide peptidase is required for virus production. J. Biol. Chem. 2008, 283:16850-16859.
10. Ashfaq U.A., et al. An overview of HCV molecular biology, replication and immune responses. Virol. J. 2011, 8:161.
11. Boulant S., et al. Structural determinants that target the hepatitis C virus core protein to lipid droplets. J. Biol. Chem. 2006, 281:22236-22247.
12. Hope R.G., et al. The domains required to direct core proteins of hepatitis C virus and GB virus-B to lipid droplets share common features with plant oleosin proteins. J. Biol. Chem. 2002, 277:4261-4270.
13. Kapoor A., et al. Characterization of a canine homolog of hepatitis C virus. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:11608-11613.
14. Drexler J.F., et al. Evidence for novel hepaciviruses in rodents. PLoS Pathog. 2013, 9:e1003438.
15. Burbelo P.D., et al. Serology-enabled discovery of genetically diverse hepaciviruses in a new host. J. Virol. 2012, 86:6171-6178.
16. Hinson E.R., Cresswell P. The antiviral protein, viperin, localizes to lipid droplets via its N-terminal amphipathic alpha-helix. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:20452-20457.
17. Stevanovic A., Thiele C. Monotopic topology is required for lipid droplet targeting of ancient ubiquitous protein 1. J. Lipid Res. 2013, 54:503-513.
18. Murugesan S., et al. Identification of diverse lipid droplet targeting motifs in the PNPLA family of triglyceride lipases. PloS ONE 2013, 8:e64950.
19. Herker E., et al. Efficient hepatitis C virus particle formation requires diacylglycerol acyltransferase-1. Nat. Med. 2010, 16:1295-1298.
20. Camus G., et al. Diacylglycerol acyltransferase-1 localizes hepatitis C virus NS5A protein to lipid droplets and enhances NS5A interaction with the viral capsid core. J. Biol. Chem. 2013, 288:9915-9923.
21. Dejgaard S.Y., et al. Rab18 and Rab43 have key roles in ER-Golgi trafficking. J. Cell Sci. 2008, 121:2768-2781.
22. Salloum S., et al. Rab18 binds to hepatitis C virus NS5A and promotes interaction between sites of viral replication and lipid droplets. PLoS Pathog. 2013, 9:e1003513.
23. Ozeki S., et al. Rab18 localizes to lipid droplets and induces their close apposition to the endoplasmic reticulum-derived membrane. J. Cell Sci. 2005, 118:2601-2611.
24. Yen C.L., et al. Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J. Lipid Res. 2008, 49:2283-2301.
25. Bulankina A.V., et al. TIP47 functions in the biogenesis of lipid droplets. J. Cell Biol. 2009, 185:641-655.
26. Ploen D., et al. TIP47 plays a crucial role in the life cycle of hepatitis C virus. J. Hepatol. 2013, 58:1081-1088.
27. Ploen D., et al. TIP47 is associated with the hepatitis C virus and its interaction with Rab9 is required for release of viral particles. Eur. J. Cell Biol. 2013, 92:374-382.
28. Vogt D.A., et al. Lipid droplet-binding protein TIP47 regulates hepatitis C virus RNA replication through interaction with the viral NS5A protein. PLoS Pathog. 2013, 9:e1003302.
29. Aivazian D., et al. TIP47 is a key effector for Rab9 localization. J. Cell Biol. 2006, 173:917-926.
30. Appel N., et al. Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog. 2008, 4:e1000035.
31. Lindenbach B.D., et al. Complete replication of hepatitis C virus in cell culture. Science 2005, 309:623-626.
32. Wakita T., et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 2005, 11:791-796.
33. Zhong J., et al. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:9294-9299.
34. Thomssen R., et al. Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins. Med. Microbiol. Immunol. 1993, 182:329-334.
35. Targett-Adams P., et al. Visualization of double-stranded RNA in cells supporting hepatitis C virus RNA replication. J. Virol. 2008, 82:2182-2195.
36. Huang L., et al. Hepatitis C virus nonstructural protein 5A (NS5A) is an RNA-binding protein. J. Biol. Chem. 2005, 280:36417-36428.
37. Stapleford K.A., Lindenbach B.D. Hepatitis C virus NS2 coordinates virus particle assembly through physical interactions with the E1-E2 glycoprotein and NS3-NS4A enzyme complexes. J. Virol. 2011, 85:1706-1717.
38. Liefhebber J.M., et al. Modulation of triglyceride and cholesterol ester synthesis impairs assembly of infectious hepatitis C virus. J. Biol. Chem. 2014, 289:21276-21288.
39. Meex S.J., et al. Huh-7 or HepG2 cells: which is the better model for studying human apolipoprotein-B100 assembly and secretion?. J. Lipid Res. 2011, 52:152-158.
40. Higashi Y., et al. Transmembrane lipid transfer is crucial for providing neutral lipids during very low density lipoprotein assembly in endoplasmic reticulum. J. Biol. Chem. 2003, 278:21450-21458.
41. Olofsson S.O., et al. Lipid droplets as dynamic organelles connecting storage and efflux of lipids. Biochim. Biophys. Acta 2009, 1791:448-458.
42. Gordon D.A. Recent advances in elucidating the role of the microsomal triglyceride transfer protein in apolipoprotein B lipoprotein assembly. Curr. Opin. Lipidol. 1997, 8:131-137.
43. Raabe M., et al. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J. Clin. Invest. 1999, 103:1287-1298.
44. von Zychlinski A., et al. Absolute quantification of apolipoproteins and associated proteins on human plasma lipoproteins. J. Proteomics 2014, 106:181-190.
45. Gusarova V., et al. Golgi-associated maturation of very low density lipoproteins involves conformational changes in apolipoprotein B, but is not dependent on apolipoprotein E. J. Biol. Chem. 2007, 282:19453-19462.
46. Gastaminza P., et al. Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J. Virol. 2008, 82:2120-2129.
47. Huang H., et al. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:5848-5853.
48. Jiang J., Luo G. Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles. J. Virol. 2009, 83:12680-12691.
49. Hueging K., et al. Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly. J. Virol. 2014, 88:1433-1446.
50. Jammart B., et al. Very-low-density lipoprotein (VLDL)-producing and hepatitis C virus-replicating HepG2 cells secrete no more lipoviroparticles than VLDL-deficient Huh7.5 cells. J. Virol. 2013, 87:5065-5080.
51. Catanese M.T., et al. Ultrastructural analysis of hepatitis C virus particles. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:9505-9510.
52. Lin C.C., et al. Apolipoprotein J, a glucose up-regulated molecular chaperone stabilizes core and NS5A to promote infectious hepatitis C virus virion production. J. Hepatol. 2014, 61:984-993.
53. Helbig K.J., et al. Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology 2005, 42:702-710.
54. Helbig K.J., et al. The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A. Hepatology 2011, 54:1506-1517.
55. Jiang D., et al. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J. Virol. 2008, 82:1665-1678.
56. Mesmin B., et al. A four-step cycle driven by PI(4)P hydrolysis directs sterol/PI(4)P exchange by the ER-Golgi tether OSBP. Cell 2013, 155:830-843.
57. Saitoh T., et al. Antiviral protein Viperin promotes Toll-like receptor 7- and Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells. Immunity 2011, 34:352-363.
58. Ohsaki Y., et al. Cytoplasmic lipid droplets are sites of convergence of proteasomal and autophagic degradation of apolipoprotein B. Mol. Biol. Cell 2006, 17:2674-2683.
59. Hooper C., et al. Spartin activates atrophin-1-interacting protein 4 (AIP4) E3 ubiquitin ligase and promotes ubiquitination of adipophilin on lipid droplets. BMC Biol. 2010, 8:72.
60. Rubbia-Brandt L., et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J. Hepatol. 2000, 33:106-115.
61. Thomopoulos K.C., et al. Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis. Eur. J. Gastroenterol. Hepatol. 2006, 18:233-237.
62. Rubbia-Brandt L., et al. Steatosis affects chronic hepatitis C progression in a genotype specific way. Gut 2004, 53:406-412.
63. Hezode C., et al. Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections. J. Viral Hepat. 2004, 11:455-458.
64. Piodi A., et al. Morphological changes in intracellular lipid droplets induced by different hepatitis C virus genotype core sequences and relationship with steatosis. Hepatology 2008, 48:16-27.
65. Hourioux C., et al. The genotype 3-specific hepatitis C virus core protein residue phenylalanine 164 increases steatosis in an in vitro cellular model. Gut 2007, 56:1302-1308.
66. Depla M., et al. Viral sequence variation in chronic carriers of hepatitis C virus has a low impact on liver steatosis. PloS ONE 2012, 7:e33749.
67. Weickert M.O., Pfeiffer A.F. Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabetologia 2006, 49:1732-1741.
68. Clement S., et al. Down-regulation of phosphatase and tensin homolog by hepatitis C virus core 3a in hepatocytes triggers the formation of large lipid droplets. Hepatology 2011, 54:38-49.
69. Bose S.K., et al. Hepatitis C virus activates the mTOR/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistance. J. Virol. 2012, 86:6315-6322.
70. Matsuzaki H., et al. Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:11285-11290.
71. Bernsmeier C., et al. Hepatitis C virus dysregulates glucose homeostasis by a dual mechanism involving induction of PGC1alpha and dephosphorylation of FoxO1. J. Viral Hepat. 2014, 21:9-18.
72. Bose S.K., et al. Forkhead box transcription factor regulation and lipid accumulation by hepatitis C virus. J. Virol. 2014, 88:4195-4203.
73. Banerjee A., et al. Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression. J. Virol. 2010, 84:5936-5946.
74. Parvaiz F., et al. Hepatitis C virus nonstructural protein 5A favors upregulation of gluconeogenic and lipogenic gene expression leading towards insulin resistance: a metabolic syndrome. Arch. Virol. 2014, 159:1017-1025.
75. Pyper S.R., et al. PPARalpha: energy combustion, hypolipidemia, inflammation and cancer. Nucl. Recept. Signal. 2010, 8:e002.
76. Dharancy S., et al. Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection. Gastroenterology 2005, 128:334-342.
77. Singaravelu R., et al. Hepatitis C virus induced up-regulation of microRNA-27: a novel mechanism for hepatic steatosis. Hepatology 2014, 59:98-108.
78. Tanaka N., et al. PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice. J. Clin. Invest. 2008, 118:683-694.
79. Lambert J.E., et al. Elevated lipogenesis and diminished cholesterol synthesis in patients with hepatitis C viral infection compared to healthy humans. Hepatology 2013, 57:1697-1704.
80. Corey K.E., et al. Hepatitis C virus infection and its clearance alter circulating lipids: implications for long-term follow-up. Hepatology 2009, 50:1030-1037.
81. Li Q., et al. Hepatitis C virus infection activates an innate pathway involving IKK-alpha in lipogenesis and viral assembly. Nat. Med. 2013, 19:722-729.
82. Oshiumi H., et al. Hepatitis C virus core protein abrogates the DDX3 function that enhances IPS-1-mediated IFN-beta induction. PloS ONE 2010, 5:e14258.
83. Angus A.G., et al. Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein. J. Gen. Virol. 2010, 91:122-132.
84. Felmlee D.J., et al. Hepatitis C virus, cholesterol and lipoproteins - impact for the viral life cycle and pathogenesis of liver disease. Viruses 2013, 5:1292-1324.
85. Isken O., et al. Functional characterization of bovine viral diarrhea virus nonstructural protein 5A by reverse genetic analysis and live cell imaging. J. Virol. 2014, 88:82-98.
86. Kapoor A., et al. Identification of rodent homologs of hepatitis C virus and pegiviruses. MBio 2013, 4. e00216-00213.
87. Melvin S.L., et al. Biophysical characterization of GB virus C from human plasma. J. Virol. Methods 1998, 71:147-157.
88. Krahmer N., et al. Phosphatidylcholine synthesis for lipid droplet expansion is mediated by localized activation of CTP:phosphocholine cytidylyltransferase. Cell Metab. 2011, 14:504-515.
89. Fei W., et al. A role for phosphatidic acid in the formation of 'supersized' lipid droplets. PLoS Genet. 2011, 7:e1002201.
90. Leikin S., et al. Measured effects of diacylglycerol on structural and elastic properties of phospholipid membranes. Biophys. J. 1996, 71:2623-2632.
91. Cheville N.F. Peroxisomes, smooth endoplasmic reticulum, and lipids. Ultrastructural Pathology: The Comparative Cellular Basis of Disease 2009, 153-180. Wiley-Blackwell, Chapter 4.
92. Thiam A.R., et al. The biophysics and cell biology of lipid droplets. Nat. Rev. Mol. Cell Biol. 2013, 14:775-786.
93. Bostrom P., et al. SNARE proteins mediate fusion between cytosolic lipid droplets and are implicated in insulin sensitivity. Nat. Cell Biol. 2007, 9:1286-1293.
94. Gong J., et al. Fsp27 promotes lipid droplet growth by lipid exchange and transfer at lipid droplet contact sites. J. Cell Biol. 2011, 195:953-963.
95. Bostrom P., et al. Cytosolic lipid droplets increase in size by microtubule-dependent complex formation. Arterioscler. Thromb. Vasc. Biol. 2005, 25:1945-1951.
96. Wilfling F., et al. Triacylglycerol synthesis enzymes mediate lipid droplet growth by relocalizing from the ER to lipid droplets. Dev. Cell 2013, 24:384-399.
97. Wang H., et al. Lipin-1gamma isoform is a novel lipid droplet-associated protein highly expressed in the brain. FEBS Lett. 2011, 585:1979-1984.
98. Sembongi H., et al. Distinct roles of the phosphatidate phosphatases lipin 1 and 2 during adipogenesis and lipid droplet biogenesis in 3T3-L1 cells. J. Biol. Chem. 2013, 288:34502-34513.
99. Xu N., et al. The FATP1-DGAT2 complex facilitates lipid droplet expansion at the ER-lipid droplet interface. J. Cell Biol. 2012, 198:895-911.